[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622606":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":25,"responsibleParty":53,"collaborators":57,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":10,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":83,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"University of British Columbia","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Pregnant participants with Inflammatory Bowel Disease (IBD)",null,"The study will include 40 consenting pregnant patients with IBD (Crohn's Disease (CD) or Ulcerative Colitis (UC)), varying in levels of severity depending on assigned SES-CD scoring (for CD patients) and Mayo score (for UC patients) from their gastroenterologist. Stool, vaginal swabs, and optional breastmilk samples and breast skin swabs will be collected using an at-home kit. The patient will receive all instructions and shipping materials in a kit delivered to their home.",{"label":13,"type":10,"description":14,"interventionNames":10},"Pregnant participants without Inflammatory Bowel Disease (IBD)","The study will include 40 consenting pregnant patients without a diagnosis of IBD. Stool, vaginal swabs, and optional breastmilk samples and breast skin swabs will be collected using an at-home kit. The patient will receive all instructions and shipping materials in a kit delivered to their home.",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Genelle Lunken, PhD, RD","CONTACT","7782327016","genelle.lunken@bcchr.ca",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Mathilde Wilhelmy","5813984638","wilhelmy@student.ubc.ca",[26,46],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"BC Children's Hospital Research Institute","NOT_YET_RECRUITING","Vancouver","British Columbia","V5Z 4H4","Canada","CA",{"type":35,"coordinates":36},"Point",[37,38],-123.11934,49.24966,{"lat":38,"lon":37},[41],{"name":42,"role":18,"phone":43,"phoneExt":44,"email":45},"Research Assistant","6042835235","202","calina.ibd@ubc.ca",{"facility":27,"status":47,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":48,"geoPoint":50,"contacts":51},"RECRUITING",{"type":35,"coordinates":49},[37,38],{"lat":38,"lon":37},[52],{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Genelle Lunken","Investigator, BC Children's Hospital Registered Dietitian, IBD Centre of BC",[58,59],{"name":27,"class":6},{"name":60,"class":61},"IBD Centre of BC","UNKNOWN","100622606","exploring-fecal-calprotectin-levels-maternal-and-infant-microbiota-infant-health-nutrition-and-adverse-pregnancy-outcomes-with-patient-with-inflammatory-bowel-disease-100622606",false,"NCT07385807","Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease","Exploring the Gut Microbiota and Dietary Contributors to Elevated Infant Fecal Calprotectin In Patients With Inflammatory Bowel Disease: A Pilot Study (CALINA-IBD)","CALINA-IBD","Inclusion Criteria:\n\nAll patients\n\n* Pregnant individuals ≥19 years recruited during their first, second or early third trimester.\n* Own or have regular access to a smartphone compatible with the study smartphone application RXFood.\n\nIBD patients\n\n● A documented IBD diagnosis (CD or UC) with active or quiescent disease.\n\nNon-IBD controls ● Absence of IBD.\n\nExclusion Criteria:\n\nAll patients\n\n* Inability to provide consent\n* Previous gastrointestinal cancer or bowel surgery\n* Renal disease\n* HIV\u002FAIDS or other serious infection\n* Fetal chromosomal or structural abnormalities\n* Other immune-mediated diseases (e.g., multiple sclerosis, rheumatoid arthritis, primary sclerosing cholangitis)\n* Prebiotic, probiotic or postbiotic supplements in the month prior to first sample collection\n* Gastroenteritis during or 1 month before the first sample collection\n* Travel outside of Canada and the United States in the month prior to first sample collection\n\nIBD patients\n\n● Pregnant individuals with active perianal or extra-intestinal disease in IBD",true,"FEMALE","19 Years",{"count":74,"type":75},80,"ESTIMATED","OBSERVATIONAL","The goal of this prospective longitudinal cohort study is to examine how the human microbiome of pregnant women-including bacteria and fungi in the gastrointestinal tract, vaginal canal, skin, and breastmilk-may influence infant gut inflammation, measured by fecal calprotectin (FCP) levels, and to identify factors that could inform dietary interventions to improve infant health outcomes. Specifically, the study aims to determine which maternal gut microbiome characteristics and dietary patterns during pregnancy are associated with elevated FCP levels in infants, and which infant gut microbiota compositions and dietary factors are linked to high FCP levels. Researchers will compare microbiome signatures and dietary factors in pregnant women and their infants with active or inactive IBD, as well as non-IBD controls, to identify microbial patterns that may predict infant gut inflammation. Participants will provide fecal samples at all study timepoints, one vaginal swab during the third trimester of pregnancy, and optional breastmilk and breast skin swab samples. They will also complete 3-day diet recalls using a smartphone app and participate in a longitudinal follow-up over 12 months after birth to monitor dietary patterns, microbiome profiles, and gut inflammation in both mother and infant.",[79,80,81,82],"IBD (Inflammatory Bowel Disease)","IBD","IBD - Inflammatory Bowel Disease","Pregnancy",[82,80,84,85,68,86],"Crohn's Disease","Ulcerative Colitis","Inflammatory Bowel Disease","2026-04-03",{"date":89,"type":90},"2026-04-06","ACTUAL",{"date":92,"type":90},"2026-03-20",{"date":94,"type":75},"2028-02-01",{"name":5,"class":6},2]